Minimizing Pain During Office Intradetrussor Botox Injection

• Status: Recruiting
• Trial end date: 2022-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

This will be a prospective double-blinded randomized controlled trial comparing two pre-treatment protocols for patients undergoing intradetrussor botox injections to determine if a buffered lidocaine solution offers superior pain control.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boston Urogynecology Associates
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Female patient

• Primary diagnosis of overactive bladder

• Failed first and second line therapy for overactive bladder

• Planning to undergo bladder botox injections

Exclusion Criteria:

• Neurogenic bladder

• Urinary retention